Top Industry Leaders in the Hepatitis C Drugs Market
Latest Hepatitis C Drugs Companies Updates:
Gilead Sciences Inc. (US) Still faces scrutiny for the high cost of its Hepatitis C drugs, particularly Sovaldi, even with discounts. However, the company continues to collaborate with public programs and insurers to broaden access.
AbbVie Inc. (US) Launched Mavyret™ (glecaprevir/pibrentasvir) in several LMICs, offering another treatment option with good efficacy and tolerability.
Hepatitis Fund Remains actively involved in advocating for affordable access to Hepatitis C drugs and supporting elimination efforts in LMICs.
List of Hepatitis C Drugs Key companies in the market:
- AbbVie Inc.
- Bristol-Myers Squibb Company
- F Hoffmann-La Roche Ltd
- Gilead Sciences, Inc.
- Johnson and Johnson
- Kadmon Holdings, Inc.
- Merck and Co., Inc.